Medtronic plc MDT

Latest FY: 2026 Healthcare Medical Devices
Market Price $93.11
Market Cap $119.20B
P/E Ratio 24.96
Quick Peer Compare (Healthcare):
Revenue (FY 2026) ↓-25.0% YoY
$383.00M
3-Yr CAGR: -0.3%
Net Income ↑3.0% YoY
$4.80B
Net Margin: 1,253.5%
Free Cash Flow ↑4.6% YoY
$5.43B
FCF Yield: 4.55%
EPS (Diluted) ↑3.3% YoY
$3.73
Basic: $3.75
Return on Equity Efficiency
9.7%
ROA: 5.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MDT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $431.0M $19,691.0M $3,538.0M $2.48 $1.52 $5,218.0M $4,172.0M
FY 2017 $366.0M -15.1% $20,419.0M $4,028.0M +13.8% $2.89 +16.5% $1.72 $6,880.0M $5,626.0M +34.9%
FY 2018 $397.0M +8.5% $20,898.0M $3,104.0M -22.9% $2.27 -21.5% $1.84 $4,684.0M $3,616.0M -35.7%
FY 2019 $373.0M -6.0% $21,402.0M $4,631.0M +49.2% $3.41 +50.2% $2.00 $7,007.0M $5,873.0M +62.4%
FY 2020 $356.0M -4.6% $19,489.0M $4,789.0M +3.4% $3.54 +3.8% $2.16 $7,234.0M $6,021.0M +2.5%
FY 2021 $336.0M -5.6% $19,634.0M $3,606.0M -24.7% $2.66 -24.9% $2.32 $6,240.0M $4,885.0M -18.9%
FY 2022 $318.0M -5.4% $21,541.0M $5,039.0M +39.7% $3.73 +40.2% $2.52 $7,346.0M $5,978.0M +22.4%
FY 2023 $386.0M +21.4% $20,508.0M $3,758.0M -25.4% $2.82 -24.4% $2.72 $6,039.0M $4,580.0M -23.4%
FY 2024 $597.0M +54.7% $21,148.0M $3,676.0M -2.2% $2.76 -2.1% $2.76 $6,787.0M $5,200.0M +13.5%
FY 2025 $511.0M -14.4% $21,905.0M $4,662.0M +26.8% $3.61 +30.8% $2.80 $7,044.0M $5,185.0M -0.3%
FY 2026 $383.0M -25.0% $23,643.0M $4,801.0M +3.0% $3.73 +3.3% $2.84 $7,330.0M $5,426.0M +4.6%
$

Valuation

Market Price $93.11
Market Cap $119.20B
Enterprise Value $145.21B
P/E Ratio 24.96
P/B Ratio 2.41
FCF Yield 4.55%
Dividend Yield 3.05%
Shares Outstanding 1,280,177,300
%

Profitability & Margins

Gross Margin 6,173.11%
Operating Margin 1,688.51%
Net Margin 1,253.52%
Return on Equity (ROE) 9.71%
Return on Assets (ROA) 5.16%
Asset Turnover 0.00x
Revenue 3-Yr CAGR -0.26%
🛡️

Financial Health & Liquidity

Current Ratio 2.13
Cash Ratio 0.17
Debt / Equity 0.565
Debt / Assets 0.301
Cash & Equivalents $1.95B
Total Debt $27.96B
Book Value / Share $38.64
💧

Cash Flow Efficiency

Operating Cash Flow $7.33B
Capital Expenditures (CapEx) $1.90B
Free Cash Flow $5.43B
OCF / Revenue 1,913.84%
FCF / Revenue 1,416.71%
FCF 3-Yr CAGR 5.81%
🏷️

Per Share Metrics

EPS (Diluted) $3.73
EPS (Basic) $3.75
Dividends / Share $2.84
Book Value / Share $38.64
EPS YoY Growth 3.32%
🏛️

Balance Sheet (FY 2026)

Total Assets $93.03B
Total Liabilities $42.96B
Stockholders' Equity $49.46B
Current Assets $24.79B
Current Liabilities $11.66B